Cerebral ischemia in young adults and genetic polymorphisms of coagulation factors II, V and VII

• References

• 1 Weih M, Junge-Hulsing J, Mehraein S. et al. Hereditary thrombophilia with ischemic stroke and sinus thrombosis. Nervenarzt 2000; 71: 936-45.
• 2 Huismann MV, Rosendaal F. Thrombophilia. Curr Opin Hematol 1999; 06: 291-7.
• 3 Bernardi F, Marchetti G, Pinotti M. et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16: 72-6.
• 4 Iacoviello L, Di Castelnuovo A, De Knijff P. et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338: 79-85.
• 5 Girelli D, Russo C, Ferraresi P. et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-80.
• 6 Hey DMwood, Carter AM, Catto AJ. et al. Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 1997; 28: 816-21.
• 7 Nishiuma S, Kario K, Nakanishi K. et al. Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls. Blood Coagul Fibrinolysis 1997; 08: 525-30.
• 8 Kain K, Catto AJ, Young J. et al. Coagulation Factor VII Activity, Arg/Gln353 Polymorphism and Features of Insulin Resistance in First-Degree-Relatives of South Asian Patients with Stroke. Thromb Haemost 2002; 88: 954-60.
• 9 Huber S, McMaster KJ, Volkerding KV. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A. J Mol Diagn 2000; 02: 153-7.
• 10 Grau AJ, Weimar C, Buggle F. et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001; 32: 2559-66.
• 11 Grossmann R, Geisen U, Merati G. et al. Genetic risk factors in young adults with 'cryptogenic' ischemic cerebrovascular disease. Blood Coagul Fibrinolysis 2002; 13: 583-90.